Evidence map›Paper›PMID 30129231›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2019

New insights into immune mechanisms of antiperlecan/LG3 antibody production: Importance of T cells and innate B1 cells.

Lauriane Padet, Mélanie Dieudé, Annie Karakeussian-Rimbaud, Bing Yang, Julie Turgeon, Jean-François Cailhier, Héloïse Cardinal, Marie-Josée Hébert

Abstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.International journal of molecular sciences · 2020
    Review
  10. Review
  11. New insights into immune mechanisms of antiperlecan/LG3 antibody production: Importance of T cells and innate B1 cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lauriane PadetResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Mélanie DieudéResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Annie Karakeussian-RimbaudResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Bing YangResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Julie TurgeonResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Jean-François CailhierResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Héloïse CardinalResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Marie-Josée HébertResearch Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.

Funding

CIHR MOP-123436CIHR PJT-148884Kidney Foundation of Canada KFOC 150009
6 · The paper itself

Abstract

Autoantibodies against perlecan/LG3 (anti-LG3) have been associated with increased risks of delayed graft function, acute rejection, and reduced long-term survival. High titers of anti-LG3 antibodies have been found in de novo renal transplants recipients in the absence of allosensitizing or autoimmune conditions. Here, we seek to understand the pathways controlling anti-LG3 production prior to transplantation. Mice immunized with recombinant LG3 produce concomitantly IgM and IgG anti-LG3 antibodies suggesting a memory response. ELISpot confirmed the presence of LG3-specific memory B cells in nonimmunized mice. Purification of B1 and B2 subtypes identified peritoneal B1 cells as the major source of memory B cells reactive to LG3. Although nonimmunized CD4-deficient mice were found to express LG3-specific memory B cells, depletion of CD4

Indexed as

Antibody FormationAnimalsAutoantibodiesB-LymphocytesDelayed Graft FunctionFemaleHeparan Sulfate ProteoglycansImmunologic MemoryKidney TransplantationMiceMice, Inbred C57BLT-LymphocytesAutoantibodiesHeparan Sulfate Proteoglycansperlecananimal modelsautoantibodybasic (laboratory) research/scienceB cell biologycell death: apoptosiscellular biologyclinical research/practiceimmunobiologykidney transplantation/nephrology

Identifiers

PMID30129231
PMCPMC6519043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.